Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Swollen Knee Treatment Market, by Type
6.1 Introduction
6.2 Medications
6.2.1 Corticosteroids
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Opioids
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Patient-controlled analgesia (PCA) pumps
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Nerve blocks
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Liposomal bupivacaine
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5 Surgery
6.5.1 Arthrocentesis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.2 Arthroscopy
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.3 Knee replacement
6.5.1.1 Total knee replacement
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.1.2 Uni-compartmental knee replacement
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.5.1.3 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Swollen Knee Treatment Market, by End-User
7.1 Introduction
7.2 Hospitals
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4 Ambulatory Surgery Centers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.5 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Swollen Knee Treatment, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Stryker Corporation
10.1.1 Company Overview
10.1.2 Type Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Zimmer Holdings
10.2.1 Company Overview
10.2.2 Type Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Smith & Nephew Plc.
10.3.1 Company Overview
10.3.2 Type Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 DePuy Companies Inc.
10.4.1 Company Overview
10.4.2 Technology/Business Segment Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Wright Medical Group Inc.
10.5.1 Company Overview
10.5.2 Type Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Biomet Inc.
10.6.1 Company Overview
10.6.2 Type Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Exactech
10.7.1 Overview
10.7.2 Type Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 B. Braun Melsungen AG
10.8.1 Overview
10.8.2 Type/ Technology Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Pfizer Pharmaceuticals, Inc.
10.9.1 Overview
10.9.2 Type Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Merck & Co.
10.10.1 Overview
10. 10.2 Type Overview
10. 10.3 Financials
10. 10.4 Key Developments
10. 10.5 SWOT Analysis
10.11 Fresenius Kabi
10.11.1 Overview
10. 11.2 Type Overview
10. 11.3 Financials
10. 11.4 Key Developments
10. 11.5 SWOT Analysis
10.12 AngioDynamics
10.12.1 Overview
10.12.2 Type Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 C.R.Bard
10.13.1 Overview
10.13.2 Type Overview
10.13.3 Financials
10.13.4 Key Developments
10.13.5 SWOT Analysis
10.14 Teleflex
10.14.1 Overview
10.14.2 Type Overview
10.14.3 Financials
10.14.4 Key Developments
10.14.5 SWOT Analysis
10.15 Smiths Medical
10.15.1 Overview
10.15.2 Type Overview
10.15.3 Financials
10.15.4 Key Developments
10.15.5 SWOT Analysis
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.2 Key Companies to Watch
11.3 Predictions for the Biosurgery Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Swollen Knee Treatment Synopsis, 2020–2027
Table 2 Global Swollen Knee Treatment Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Swollen Knee Treatment, by Region, 2020–2027 (USD Million)
Table 4 Global Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 6 Global Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 7 North America: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 8 North America: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 9 US: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 10 US: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 11 Canada: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 12 Canada Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 13 South America: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 14 South America: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 15 Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD Million)
Table 16 Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 17 Western Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 18 Western Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 19 Eastern Europe: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 20 Eastern Europe: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 21 Asia-Pacific: Swollen Knee Treatment, by Type, 2020–2027 (USD
Million)
Table 22 Asia-Pacific: Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Table 23 Middle East & Africa: Swollen Knee Treatment, by Type, 2020–2027
(USD Million)
Table 24 Middle East & Africa Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Swollen Knee Treatment
Figure 3 Segmentation Market Dynamics for Global Swollen Knee Treatment
Figure 4 Global Swollen Knee Treatment Share, by Type, 2020
Figure 5 Global Swollen Knee Treatment Share, by Structure, 2020
Figure 6 Global Swollen Knee Treatment Share, by Application, 2020
Figure 7 Global Swollen Knee Treatment, by End-User, 2020–2027 (USD Million)
Figure 8 Global Swollen Knee Treatment Share, by Region, 2020
Figure 9 North America: Swollen Knee Treatment Share, by Country, 2020
Figure 10 Europe: Swollen Knee Treatment Share, by Country, 2020
Figure 11 Asia-Pacific: Swollen Knee Treatment Share, by Country, 2020
Figure 12 Middle East & Africa: Swollen Knee Treatment Share, by Country, 2020
Figure 13 Global Swollen Knee Treatment: Company Share Analysis, 2020 (%)
Figure 14 Stryker Corporation: Key Financials
Figure 15 Stryker Corporation: Segmental Revenue
Figure 16 Stryker Corporation: Geographical Revenue
Figure 17 Zimmer Holdings: Key Financials
Figure 18 Zimmer Holdings: Segmental Revenue
Figure 19 Zimmer Holdings: Geographical Revenue
Figure 20 Smith & Nephew Plc.: Key Financials
Figure 21 Smith & Nephew Plc.: Segmental Revenue
Figure 22 Smith & Nephew Plc.: Geographical Revenue
Figure 23 DePuy Companies, Inc.: Key Financials
Figure 24 DePuy Companies, Inc.: Segmental Revenue
Figure 25 DePuy Companies, Inc.: Geographical Revenue
Figure 26 Wright Medical Group Inc.: Key Financials
Figure 27 Wright Medical Group Inc.: Segmental Revenue
Figure 28 Wright Medical Group Inc.: Geographical Revenue
Figure 27 Biomet Inc.: Key Financials
Figure 30 Biomet Inc.: Segmental Revenue
Figure 31 Biomet Inc.: Geographical Revenue
Figure 32 Exactech: Key Financials
Figure 33 Exactech: Segmental Revenue
Figure 34 Exactech: Geographical Revenue
Figure 35 B. Braun Melsungen AG: Key Financials
Figure 36 B. Braun Melsungen AG: Segmental Revenue
Figure 37 B. Braun Melsungen AG: Geographical Revenue
Figure 38 Pfizer Pharmaceuticals Inc.: Key Financials
Figure 37 Pfizer Pharmaceuticals Inc.: Segmental Revenue
Figure 40 Pfizer Pharmaceuticals Inc.: Geographical Revenue
Figure 41 Merck & Co.: Key Financials
Figure 42 Merck & Co.: Segmental Revenue
Figure 43 Merck & Co.: Geographical Revenue
Figure 44 Fresenius Kabi: Key Financials
Figure 45 Fresenius Kabi: Segmental Revenue
Figure 46 Fresenius Kabi: Geographical Revenue
Figure 47 AngioDynamics: Key Financials
Figure 48 AngioDynamics: Segmental Revenue
Figure 47 AngioDynamics: Geographical Revenue
Figure 50 C.R.Bard: Key Financials
Figure 51 C.R.Bard: Segmental Revenue
Figure 52 C.R.Bard: Geographical Revenue
Figure 53 Teleflex: Key Financials
Figure 54 Teleflex: Segmental Revenue
Figure 55 Teleflex: Geographical Revenue
Figure 56 Smiths Medical: Key Financials
Figure 57 Smiths Medical: Segmental Revenue
Figure 58 Smiths Medical: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
